Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics, other
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2015
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
test procedure in accordance with national standard methods

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2015

Materials and methods

Objective of study:
other: receptor binding
GLP compliance:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Insulin Aspart Precursor
EC Number:
944-549-2
Molecular formula:
C302H446N76O91S7
IUPAC Name:
Insulin Aspart Precursor
Test material form:
solid: crystalline

Results and discussion

Preliminary studies:
From insulin receptor binding assays (Novo Nordisk 2015) the following relative binding was observed for insulin APIs and the various insulin intermediates:                        
Human insulin (API, two chains):               100 %                                                                                                                                                                                             
Human insulin methyl ester (two chains):    108 %                                                                                                                                                                                                
DesB 30 human insulin (two chains) :   133 %                                                                                                                                                                  
X14DesB30 (S3, two chains):  not examined                                                                                                                                                                            Insulin aspart (API, S1, two chains):     100% %                                                                                                                                                                                                                  
Insulin aspart ethyl ester (two chains):     103%                                                                                                                                                                                                                                                                                                                                                    
Insulin aspart precursor (T, one chain) :   0.03 %                                                                                                                                                                                               
MI3 (S2, one chain):   0.22%                                                                                                                                                                                                                                                                                                                                                                                                                                                 
These data indicate that receptor binding affinity is lost when the two amino acids chains are linked together in one chain,
most probably due to a great change in the steric form of the molecule.

Any other information on results incl. tables

From insulin receptor binding assays (Novo Nordisk 2015) the following relative binding was observed for insulin APIs and the various insulin intermediates:                        

Human insulin (API, two chains):               100 %                                                                                                                                                                                             

Human insulin methyl ester (two chains):    108 %                                                                                                                                                                                                

DesB 30 human insulin (two chains) :        133 %                                                                                                                                                                  

X14DesB30 (S3, two chains):                   not examined                                                                                                                                                                           

Insulin aspart (API, S1, two chains):          100 %                                                                                                                                                                                                                  

Insulin aspart ethyl ester (two chains):      103%                                                                                                                                                                                                                                                                                                                                                    

Insulin aspart precursor (T, one chain) :   0.03 %                                                                                                                                                                                               

MI3 (S2, one chain):   0.22%                                                                                                                                                                                                                                                                                                                                                                                                                                                 

These data indicate that receptor binding affinity is lost when the two amino acids chains are linked together in one chain,

most probably due to a great change in the steric form of the molecule.

Applicant's summary and conclusion

Conclusions:
Human insulin receptor affinity of insulin aspart precurser relative to the API, insulin aspart, was found to be 0.03% [0.02 to 0.06]. Results are given as weighted means of three independent experiments with the corresponding 95% confidence intervals
Executive summary:

Human insulin receptor affinity of insulin aspart precurser relative to the API, insulin aspart, was found to be 0.03% [0.02 to 0.06]. Results are given as weighted means of three independent experiments with the corresponding 95% confidence intervals.